CPT1C adenovirus

CPT1C, or carnitine palmitoyltransferase 1C, is a key gene that encodes an enzyme involved in mitochondrial fatty acid oxidation. Located on human chromosome 22, the CPT1C gene plays an important role in lipid metabolism and energy homeostasis. Unlike CPT1A and CPT1B, which are primarily expressed in liver and muscle tissue, CPT1C is primarily found in the brain and is considered integral to regulating fatty acid metabolism in neural tissues. The protein product of the CPT1C gene promotes the transport of long-chain fatty acids across the mitochondrial membrane, which is crucial for β-oxidation, the process of generating ATP (adenosine triphosphate) from fat stores. Furthermore, recent studies suggest that CPT1C may be involved in neurological function and disease, as altered expression has been linked to conditions such as obesity and neurodegeneration.

The CPT1C adenovirus is a recombinant adenovirus used for gene therapy and molecular biology research, designed to deliver the CPT1C gene to target cells. Adenovirus is a well-characterized vector known for its ability to efficiently transduce a variety of cell types, including dividing and non-dividing cells. Using CPT1C adenovirus, researchers can manipulate CPT1C expression, study its metabolic pathways, and assess its effects on cellular function. Furthermore, the versatility of adenoviral vectors facilitates long-term expression of therapeutic genes, making them a promising candidate for translational medicine. The CPT1C gene and its corresponding adenovirus are crucial for advancing our understanding of mitochondrial fatty acid oxidation and its impact on health and disease. Furthermore, ongoing research with CPT1C adenovirus holds the potential to open new avenues for the treatment of metabolic and neurological diseases.